Companies & Industry »Company News»Company News Details
Company News Details

BSE   24 Nov 14 | 12:00 AM

1550.50 -13.1 (-0.84%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   24 Nov 14 | 12:00 AM

1547.60 -16.2 (-1.04%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,545.75 (0.31%)
1 Month : Rs 1,377.50 (12.56%)
1 Year : Rs 747.75 (107.36%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Tata Power Co.91.754.14
Hindalco Inds.165.553.37
Infosys4,273.903.08
Tata Steel476.603.00
ICICI Bank1,772.952.25

Online Portfolio

You can create Online Portfolio here using the below button.